REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,341,151 | +15.1% | 42,577 | +2.7% | 0.00% | 0.0% |
| Q1 2023 | $3,770,998 | +153.6% | 41,476 | +6.0% | 0.00% | +100.0% |
| Q4 2022 | $1,487,005 | +99.1% | 39,142 | +31.8% | 0.00% | +100.0% |
| Q3 2022 | $747,000 | -16.8% | 29,690 | +0.5% | 0.00% | 0.0% |
| Q2 2022 | $898,000 | -2.5% | 29,532 | +5.0% | 0.00% | 0.0% |
| Q1 2022 | $921,000 | +29.5% | 28,125 | +4.3% | 0.00% | – |
| Q4 2021 | $711,000 | -74.5% | 26,960 | -2.8% | 0.00% | -100.0% |
| Q3 2021 | $2,789,000 | -23.3% | 27,725 | +7.9% | 0.00% | 0.0% |
| Q2 2021 | $3,636,000 | +46.0% | 25,699 | +2.8% | 0.00% | +100.0% |
| Q1 2021 | $2,491,000 | -2.6% | 24,994 | +20.9% | 0.00% | 0.0% |
| Q4 2020 | $2,557,000 | +33.8% | 20,679 | +5.4% | 0.00% | 0.0% |
| Q3 2020 | $1,911,000 | -36.4% | 19,623 | +1.8% | 0.00% | -50.0% |
| Q2 2020 | $3,006,000 | -28.2% | 19,268 | -33.6% | 0.00% | -50.0% |
| Q1 2020 | $4,187,000 | -51.9% | 29,009 | -31.9% | 0.00% | -33.3% |
| Q4 2019 | $8,711,000 | +420.7% | 42,612 | +104.5% | 0.01% | +500.0% |
| Q3 2019 | $1,673,000 | +21.5% | 20,836 | +42.7% | 0.00% | 0.0% |
| Q2 2019 | $1,377,000 | -43.5% | 14,603 | -48.8% | 0.00% | -50.0% |
| Q1 2019 | $2,439,000 | +88.0% | 28,525 | +23.4% | 0.00% | +100.0% |
| Q4 2018 | $1,297,000 | -26.4% | 23,115 | +7.2% | 0.00% | -50.0% |
| Q3 2018 | $1,763,000 | +118.7% | 21,566 | -6.4% | 0.00% | +100.0% |
| Q2 2018 | $806,000 | +114.4% | 23,052 | +25.7% | 0.00% | – |
| Q1 2018 | $376,000 | -25.1% | 18,344 | +3.4% | 0.00% | – |
| Q4 2017 | $502,000 | +78.0% | 17,738 | +96.0% | 0.00% | – |
| Q3 2017 | $282,000 | – | 9,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |